D-0340-2026 Class II Ongoing

Recalled by Meitheal Pharmaceuticals, Inc — Chicago, IL

Recall Details

Product Type
Drugs
Report Date
February 18, 2026
Initiation Date
February 9, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,477 kits

Product Description

Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.

Reason for Recall

Defective Delivery System: Missing or duplicated needles within the injection kit

Distribution Pattern

U.S. Nationwide

Code Information

Lot Q4E0112A, Exp.: 30 Apr 2027